• 1
    Wozniak J. Pediatric bipolar disorder: The new perspective on severe mood dysfunction in children. J Child Adolesc Psychopharmacol 2003;13:449451.
  • 2
    Geller B, Fox L, Clark K. Rate and predictors of prepubertal bipolarity during follow-up 6- to 12-year-old depressed children. J Am Acad Child Adolesc Psychiatry 1994;33:461468.
  • 3
    Lewinsohn P, Klein D, Seeley J. Bipolar disorders in a community sample of older adolescents: Prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry 1995;34:454463.
  • 4
    Biederman J, Mick E, Faraone SV, Spencer T, Wilens TE, Wozniak J. Pediatric mania: A developmental subtype of bipolar disorder? Biol Psychiatry 2000;48:458466.
  • 5
    Biederman J, Mick E, Bostic J, et al. The naturalistic course of pharmacologic treatment of children with manic-like symptoms: A systematic chart review. J Clin Psychiatry 1998;59:628637; quiz 38.
  • 6
    Tohen M, Ketter TA, Zarate CA, et al. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: A 47-week study. Am J Psychiatry 2003;160:12631271.
  • 7
    Keck PE Jr, Versiani M, Potkin S, West SA, Giller E, Ice K. Ziprasidone in the treatment of acute bipolar mania: A three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry 2003;160:741748.
  • 8
    Perlis RH, Welge JA, Vornik LA, Hirschfeld RM, Keck PE Jr. Atypical antipsychotics in the treatment of mania: A meta-analysis of randomized, placebo-controlled trials. J Clin Psychiatry 2006;67:509516.
  • 9
    Frazier JA, Biederman J, Tohen M, et al. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 2001;11:239250.
  • 10
    Biederman J, Mick E, Wozniak J, Aleardi M, Spencer T, Faraone SV. An open-label trial of risperidone in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 2005;15:311317.
  • 11
    Biederman J, Mick E, Hammerness P, et al. Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-aged children. Biol Psychiatry 2005;58:589594.
  • 12
    DelBello MP, Kowatch RA, Adler CM, et al. A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry 2006;45:305313.
  • 13
    Bowden C, Calabrese J, McElroy S, et al. The efficacy of Lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biol Psychiatry 1999;45:953958.
  • 14
    Bowden CL, Asnis GM, Ginsberg LD, Bentley B, Leadbetter R, White R. Safety and tolerability of lamotrigine for bipolar disorder. Drug Safety 2004;27:173184.
  • 15
    Fatemi SH, Rapport DJ, Calabrese JR, Thuras P. Lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 1997;58:522527.
  • 16
    Passmore MJ, Garnham J, Duffy A, et al. Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine. Bipolar Disord 2003;5:110114.
  • 17
    Obrocea GV, Dunn RM, Frye MA, et al. Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders. Biol Psychiatry 2002;51:253260.
  • 18
    Marangell LB, Martinez JM, Ketter TA, et al. Lamotrigine treatment of bipolar disorder: Data from the first 500 patients in STEP-BD. Bipolar Disord 2004;6:139143.
  • 19
    Calabrese JR, Suppes T, Bowden CL, et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 2000;61:841850.
  • 20
    Sporn J, Sachs G. The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J Clin Psychopharmacol 1997;17:185189.
  • 21
    Yatham LN, Kusumakar V, Parikh SV, et al. Bipolar depression: Treatment options. Can J Psychiatry 1997;42(Suppl 2):87S91S.
  • 22
    Ichim L, Berk M, Brook S. Lamotrigine compared with lithium in mania: A double-blind randomized controlled trial. Ann Clin Psychiatry 2000;12:510.
  • 23
    Calabrese JR, Sullivan JR, Bowden CL, et al. Rash in multicenter trials of lamotrigine in mood disorders: Clinical relevance and management. J Clin Psychiatry 2002;63:10121019.
  • 24
    Orvaschel H, Puig-Antich J. Schedule for Affective Disorders and Schizophrenia for School-Age Children: Epidemiologic Version. Fort Lauderdale , FL : Nova University, 1987.
  • 25
    Fristad MA, Weller RA, Weller EB. The Mania Rating Scale (MRS): Further reliability and validity studies with children. Ann Clin Psychiatry 1995;7:127132.
  • 26
    Fristad MA, Weller EB, Weller RA. The Mania Rating Scale: Can it be used in children? A preliminary report. J Am Acad Child Adolesc Psychiatry 1992;31:252257.
  • 27
    Young R, Biggs J, Ziegler V, Meyer D. A rating scale for mania: Reliability, validity and sensitvity. Br J Psychiatry 1978;133:429435.
  • 28
    Youngstrom EA, Danielson CK, Findling RL, Gracious BL, Calabrese JR. Factor structure of the Young Mania Rating Scale for use with youths ages 5 to 17 years. J Clin Child Adolesc Psychol 2002;31:567572.
  • 29
    Poznanski EO, Cook SC, Carroll BJ. A depression rating scale for children. Pediatrics 1979;64:442450.
  • 30
    Lachar D, Bailley SE, Rhoades HM, et al. New subscales for an anchored version of the brief psychiatric rating scale: Construction, reliability, and validity in acute psychiatric admissions. Psychol Assess 2001;13:384395.
  • 31
    National Institute of Mental Health. CGI (Clinical Global Impression) Scale–NIMH. Psychopharmacol Bull 1985;21:839844.
  • 32
    Chang K, Saxena K, Howe M. An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry 2006;45:298304.
  • 33
    Kowatch RA, Suppes T, Carmody TJ, et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2000;39:713720.
  • 34
    Pavuluri MN, Henry DB, Carbray JA, Naylor MW, Janicak PG. Divalproex sodium for pediatric mixed mania: A 6-month prospective trial. Bipolar Disord 2005;7:266273.
  • 35
    Wagner KD, Weller E, Carlson GA, et al. An open-label trial of divalproex in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2002;41:12241230.
  • 36
    Redden L, DelBello M, Wagner KD, et al. Long-term safety of divalproex sodium extended-release in children and adolescents with bipolar I disorder. J Child Adolesc Psychopharmacol 2009;19:8389.
  • 37
    Wagner KD, Redden L, Kowatch RA, et al. A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 2009;48:519532.
  • 38
    Weisler RH, Hirschfeld R, Cutler AJ, et al. Extended-release carbamazepine capsules as monotherapy in bipolar disorder: Pooled results from two randomised, double-blind, placebo-controlled trials. CNS Drugs 2006;20:219231.
  • 39
    Joshi G, Wozniak J, Mick E, et al. A prospective open-label trial of extended release carbamazepine (Equetro®) monotherapy in children with bipolar disorder. J Child Adolesc Psychopharmacol 2009; in press.
  • 40
    Wagner KD, Kowatch RA, Emslie GJ, et al. A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Am J Psychiatry 2006;163:11791186.
  • 41
    Calabrese J, Bowden C, Sachs G, Ascher J, Monaghan E, Rudd D. A double-blind placebo-controlled study of lamotrigine, monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999;60:7988.
  • 42
    Goodwin GM, Bowden CL, Calabrese JR, et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004;65:432441.
  • 43
    Chang KD, Wagner C, Garrett A, Howe M, Reiss A. A preliminary functional magnetic resonance imaging study of prefrontal-amygdalar activation changes in adolescents with bipolar depression treated with lamotrigine. Bipolar Disord 2008;10:426431.
  • 44
    Soutullo CA, Diez-Suarez A, Figueroa-Quintana A. Adjunctive lamotrigine treatment for adolescents with bipolar disorder: Retrospective report of five cases. J Child Adolesc Psychopharmacol 2006;16:357364.
  • 45
    Tohen M, Zarate CA Jr., Centorrino F, Hegarty JI, Froeschl M, Zarate SB. Risperidone in the treatment of mania. J Clin Psychiatry 1996;57:249253.
  • 46
    Wozniak J, Biederman J, Kiely K, et al. Mania-like symptoms suggestive of childhood onset bipolar disorder in clinically referred children. J Am Acad Child Adolesc Psychiatry 1995;34:867876.
  • 47
    Wozniak J, Biederman J, Faraone S, et al. Mania in children with pervasive developmental disorder revisited. J Am Acad Child Adolesc Psychiatry 1997;36:15521560.
  • 48
    Biederman J, Faraone SV, Mick E, et al. Attention deficit hyperactivity disorder and juvenile mania: An overlooked comorbidity? J Am Acad Child Adolesc Psychiatry 1996;35:9971008.
  • 49
    Koehler-Troy C, Strober M, Malenbaum R. Methylphenidate-induced mania in a prepubertal child. J Clin Psychiatry 1986;47:566567.
  • 50
    Schmidt K, Delaney MA, Jensen M, Levinson DF, Lewitt M. Methylphenidate challenge in a manic boy. Biol Psychiatry 1986;21:11071109.
  • 51
    Soutullo CA, DelBello MP, Ochsner JE, McElroy SL, Taylor SA, Strakowski SM, Keck PE Jr. Severity of bipolarity in hospitalized manic adolescents with history of stimulant or antidepressant treatment. J Affect Disord 2002;70:323327.